Records containing: Prostatic Neoplasms

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-06-17
  A Phase II Open Label Study of CB7630 (Abiraterone Acetate) and Prednisone in Patients With Advanced Prostate Cancer Who Have Failed Androgen Deprivation and Docetaxel-Based Chemotherapy
• CLINICAL_TRIALS study record update · 2013-05-20
  A Randomized, Double-blind, Multicenter, Phase 2 Study of a Human Monoclonal Antibody to Human av Integrins (CNTO 95) in Combination With Docetaxel for the First-Line Treatment of Subjects With Metastatic Hormone Refractory Prostate Cancer
• CLINICAL_TRIALS study record update · 2013-05-16
  A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate (CB7630) Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
• CLINICAL_TRIALS study record update · 2013-04-11
  A Phase 2, Randomized, Non-Comparative, Two-Arm Open Label, Multiple-Center Study Of CP-751,871 In Combination With Docetaxel/Prednisone In Chemotherapy- Naive (Arm A) And Docetaxel/Prednisone Refractory (Arm B) Patients With Hormone Insensitive Prostate Cancer
• CLINICAL_TRIALS study record update · 2013-03-08
  A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-02-07
  Cancer Survivors Online Self-Management Workshop
• CLINICAL_TRIALS study record update · 2013-01-28
  A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-12-11
  A Phase 2 Open-Label Study to Investigate the Pharmacodynamics and Clinical Activity of IPI-504 in Patients With Castration-Resistant Prostate Cancer Stratified by Prior Chemotherapy
• CLINICAL_TRIALS study record update · 2012-12-05
  Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-11-14
  A Phase II Trial of Docetaxel, Thalidomide, Prednisone and Bevacizumab in Patients With Androgen-Independent Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-11-07
  Clinical Evaluation of the PROGENSA(R) PCA3 Assay in Men With a Previous Negative Biopsy Result
• CLINICAL_TRIALS study record update · 2012-09-26
  A Prospective, Randomised, Double-Blind, Placebo-Controlled Phase III Study of Modafinil to Improve Fatigue and Quality of Life in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-09-07
  BONA (Adherence of Patients to Bonefos Therapy). Prospective Observational Non-interventional Study of Adherence of Patients to Bonefos Medication in Relation to Analgesic Effect and Incidence of Skeletal Events
• CLINICAL_TRIALS study record update · 2012-08-31
  ClinicalTrials.gov study NCT00055471
• CLINICAL_TRIALS study record update · 2012-07-09
  An Multicenter, Randomized Study of Comparison of Docetaxel Plus Prednisone With Mitoxantrone Plus Prednisone in the Patients With Hormone-refractory (Androgen-independent) Metastatic Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-06-07
  ClinicalTrials.gov study NCT00048659
• CLINICAL_TRIALS study record update · 2012-06-06
  A Phase 1, Open Label, Non-Randomized, Dose Escalation Study to Evaluate the Safety of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and a Phase 2, Open Label, Randomized Study to Evaluate the Efficacy of CP-675,206 in Combination With Neoadjuvant Androgen Ablation and Androgen Ablation Alone in Patients With High Risk Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-03-29
  Amifostine as a Rectal Protector During External Beam Radiotherapy for Prostate Cancer: A Phase II Study
• CLINICAL_TRIALS study record update · 2012-02-23
  A Phase I/II Pilot Study of Sequential Vaccinations With rFowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM) Alone, or in Combination With rVaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM), and the Role of GM-CSF, in Men With Prostate Cancer
• CLINICAL_TRIALS study record update · 2012-02-10
  A Phase I Study of In-Situ, Neoadjuvant, Pre-Radical Prostatectomy RTVP-1 Gene Therapy in Patients With Locally Advanced Adenocarcinoma of the Prostate (SPORE)
• CLINICAL_TRIALS study record update · 2012-02-06
  Evaluating the Effect of the Vacuum Constriction Device on Erectile Function and Penile Length Post Radical Retropubic Prostatectomy
• CLINICAL_TRIALS study record update · 2012-01-31
  A Phase 1/2, Open Label Study in Men With Prostate Cancer to Assess the Safety. Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448, Administered as a 1-Month Depot, Including a Randomized Portion With a Group Administered Leuprorelin
• CLINICAL_TRIALS study record update · 2012-01-23
  A Multicenter, Open-Label, Randomized, Phase III Trial Comparing Immediate Adjuvant Hormonal Therapy (ELIGARD®- Leuprolide Acetate) in Combination With TAXOTERE® (Docetaxel) Administered Every Three Weeks Versus Hormonal Therapy Alone Versus Deferred Therapy Followed by the Same Therapeutic Options in Patients With Prostate Cancer at High Risk of Relapse After Radical Prostatectomy
• CLINICAL_TRIALS study record update · 2011-10-24
  Phase II Study of SGN-15 (cBR96 - Doxorubicin Immunoconjugate) Combined With Taxotere in Patients With Hormone Refractory Prostate Carcinoma
• CLINICAL_TRIALS study record update · 2011-06-29
  Phase I/II, Open Label Study of Sequential Taxotere® (Docetaxel) and Gleevec® (Imatinib Mesylate) in Hormone Refractory Prostate Cancer